Florymar Alvarez
Internal Medicine · Waterbury, CTNPI 1811419377
Payments from drug & device makers
Across 153 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$962
- AbbVie$464
- Boehringer Ingelheim$351
- Pfizer$306
- Amgen$204
- Exact Sciences$192
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,38597%
- Education$1183%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $962 |
| AbbVie | 18 | $464 |
| Boehringer Ingelheim | 14 | $351 |
| Pfizer | 16 | $306 |
| Amgen | 10 | $204 |
| Exact Sciences | 10 | $192 |
| Novo Nordisk | 10 | $190 |
| Bayer | 5 | $126 |
| Lilly USA, LLC | 5 | $99 |
| Johnson & Johnson | 3 | $69 |
| GSK | 3 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Abbott | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Ardelyx, Inc. | 2 | $37 |
| Redhill Biopharma Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Novartis | 2 | $30 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Mannkind Corporation | 1 | $20 |
| Medtronic | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Viiv Healthcare Company | 1 | $16 |
| Sanofi | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,503 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 82 | $106,621 |
| JardianceEmpagliflozin | 60 | $78,068 |
| FarxigaDapagliflozin Propanediol | 39 | $52,223 |
| Repatha SyringeEvolocumab | 39 | $23,547 |
| JanuviaSitagliptin Phosphate | 24 | $21,278 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 16 | $21,216 |
| LinzessLinaclotide | 15 | $20,640 |
| TrulicityDulaglutide | 14 | $19,419 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $15,569 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 15 | $13,681 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $8,980 |
| VascepaIcosapent Ethyl | 22 | $5,409 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $5,283 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $2,432 |
| Atorvastatin Calcium | 255 | $1,911 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $190 | $106,62182 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $351 | $91,74875 claims |
| AstraZenecaFarxiga | $962 | $52,22339 claims |
| MerckJanuvia, Janumet Xr | $18 | $42,49440 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $67 | $24,54947 claims |
| AbbVieLinzess | $464 | $20,64015 claims |
| Lilly USA, LLCTrulicity | $99 | $19,41914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Waterbury
- Joseph SouferWaterbury$21.5M
- Elie HelouWaterbury$184K
- Oltjon AlbajramiWaterbury$57K
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Michelle MallitzTrumbull$971K
- Allen HellerWoodbridge$758K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.